Cell Therapy and Regenerative Medicine Distinguished Research Forum – July 2026

/in , , /by

Cell Therapy and Regenerative Medicine is one of the University’s key strategic research initiatives under the 4+2+X Development Program, with integration and implementation supported by the University-level Cell Therapy and Regenerative Medicine Research Center.

We are pleased to invite Mr. Chieh-Liang Lin, Chief Operating Officer (COO) and Chief Technology Officer (CTO) of Taiwan Exosome Company, to share his expertise at the July Cell Therapy and Regenerative Medicine Distinguished Research Forum.

Event Information

Date & Time: July 15, 2026 (Wednesday), 10:00–11:00 AM
Venue: Cisco WebEx Online Meeting
https://reurl.cc/18DmAD

Meeting Number: 2519 394 6334
Password: 20260715

Speaker

Mr. Chieh-Liang Lin
Chief Operating Officer (COO) & Chief Technology Officer (CTO)
Taiwan Exosome Company

Topic

Revolutionizing Nephritis Treatment: The TEC-NKEXO Platform – A Multi-Mechanistic, Biologically Intelligent, Cell-Free Regeneration Strategy

Registration

TMU Faculty and Staff
Talent Development System
https://ehrd.tmu.edu.tw/eHRD/eHRDOrg

Students, Research Assistants, and External Participants
TMU Academic Events Portal
https://event.tmu.edu.tw/actnews/index.php?Sn=114

We warmly welcome all faculty members, students, researchers, and interested participants to register and join us.